Revolution Medicines Inc

RVMDNASDAQ · USD
199.86USD0.00 (+4.79%)
1110

Revolution Medicines Inc (RVMD) Straddle

RVMD straddle scan found 328 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 52.3%.

Read more

Trading a RVMD straddle lets you take a pure volatility position on Revolution Medicines Inc without committing to a direction. Revolution Medicines Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate RVMD straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on RVMD profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Revolution Medicines Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the RVMD straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants.

Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the RVMD straddle is the cleanest expression of that view. Our scanner prices every RVMD straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a RVMD straddle into a catalyst or short a RVMD straddle to harvest decay, the options straddle setups that matter are all in one place.

May 21, 2027330.00$143.152403%52.3%$473.15$186.850
Mar 19, 2027330.00$141.551773%52.2%$471.55$188.450
Mar 19, 2027320.00$131.931773%52.0%$451.93$188.080
May 21, 2027320.00$134.152403%51.9%$454.15$185.850
Dec 18, 2026280.00$90.03863%51.9%$370.03$189.980
Jan 15, 2027300.00$110.701143%51.7%$410.70$189.300
Mar 19, 2027310.00$122.551773%51.6%$432.55$187.450
Aug 20, 2027330.00$147.953313%51.6%$477.95$182.050
Jan 15, 2027330.00$140.851143%51.6%$470.85$189.150
May 21, 2027310.00$125.102403%51.5%$435.10$184.900

As of September 23, 2026

Find the right straddle before volatility moves

Track RVMD straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial